Insight Molecular Diagnostics Inc
NASDAQ:IMDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Insight Molecular Diagnostics Inc
NASDAQ:IMDX
|
US |
|
Topdanmark A/S
CSE:TOP
|
DK |
|
Amlogic Shanghai Co Ltd
SSE:688099
|
CN |
|
Chill Brands Group PLC
LSE:CHLL
|
UK |
|
Vanquis Banking Group PLC
LSE:VANQ
|
UK |
|
M
|
MCT Bhd
KLSE:MCT
|
MY |
|
TransAct Technologies Inc
NASDAQ:TACT
|
US |
Wall Street
Price Targets
IMDX Price Targets Summary
Insight Molecular Diagnostics Inc
According to Wall Street analysts, the average 1-year price target for
IMDX
is 8.5 USD
with a low forecast of 4.04 USD and a high forecast of 12.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IMDX's stock price target?
Price Target
8.5
USD
According to Wall Street analysts, the average 1-year price target for
IMDX
is 8.5 USD
with a low forecast of 4.04 USD and a high forecast of 12.6 USD.
What is Insight Molecular Diagnostics Inc's Revenue forecast?
Projected CAGR
44%
The
compound annual growth rate
of
Insight Molecular Diagnostics Inc's revenue for the next 2 years is
44%.